Neurotoxic properties of cerebrospinal fluid from behaviorally impaired autoimmune mice

Brain Research

Volumn 920, Issue 1-2, 2001, Pages 183-193

  Maric, Dragan ^a   Millward, Jason M ^b   Ballok, David A ^b   Szechtman, Henry ^b   Denburg, Judah A ^b   Barker, Jeffery L ^a   Sakic, Boris ^b  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Astrocyte; Autoimmunity; Cell culture; Cerebrospinal fluid; Fluorescence; MRL mouse; Neuropsychiatric lupus; Neurotoxicity; Pyramidal neuron

Indexed keywords

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; AUTOIMMUNE DISEASE; BRAIN NERVE CELL; CELL CULTURE; CELL VIABILITY; CEREBROSPINAL FLUID; CONTROLLED STUDY; FLUORESCENCE; FOOD INTAKE; IMMOBILIZATION; IN VITRO STUDY; INCUBATION TIME; LUPUS ERYTHEMATOSUS; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SERUM; SWIMMING;

ANIMALS; ASTROCYTES; AUTOIMMUNITY; BEHAVIOR, ANIMAL; BRAIN; CELL SURVIVAL; CEREBROSPINAL FLUID; COCULTURE TECHNIQUES; DRINKING; EATING; HIPPOCAMPUS; MALE; MICE; MICE, INBRED MRL LPR; MOTOR ACTIVITY; NEURONS; NEUROTOXICITY SYNDROMES; PYRAMIDAL CELLS; SWIMMING;

EID: 0035976557     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(01)03060-8     Document Type: Article

References (75)

1. Glial cells in neurotoxicity development
2. Soluble L-selectin levels in serum and cerebrospinal fluid in patients with multiple sclerosis and systemic lupus erythematosus
3. Cytokine expression in the nervous system
4. The role of glial nitric oxide in neurotoxicity and CNS diseases
5. Evidence of central nervous system damage in patients with neuropsychiatric systemic lupus erythematosus, demonstrated by magnetization transfer imaging
6. Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination
7. Animal models for nervous system disease in systemic lupus erythematosus
8. Neurochemistry of brain lesions determined by spectroscopic imaging in systemic lupus erythematosus
9. Central nervous system nitric oxide formation in cerebral systemic lupus erythematosus
10. Prevalence of cognitive impairment in systemic lupus erythematosus
11. Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus
12. Detection of brain-reactive autoantibodies in the sera of autoimmune mice using ELISA
13. Cervical lymphatics, the blood-brain barrier, and immunoreactivity of the brain
14. Cognitive impairment in systemic lupus erythematosus: A neuropsychological study of individual and group deficits
15. Psychological aspects of systemic lupus erythematosus: Cognitive function, mood, and self-report
16. Brain, behaviour and lupus
17. A behavior profile of the MRL/Mp lpr/lpr mouse and its association with hydrocephalus
18. Effect of cyclophosphamide on leucocytic infiltration in the brain of MRL/lpr mice
19. Improvements in obtaining and characterizing mouse cerebrospinal fluid
20. Clinical and serologic manifestations of autoimmune disease in MRL-lpr/lpr mice lacking nitric oxide synthase type 2
21. Cognitive and neurologic deficits in the MRL/lpr mouse: A clinicopathologic study
22. Brain-reactive autoantibody levels in the sera of ageing autoimmune mice
23. CNS lupus and the blood-brain barrier
24. Disturbed immuno-endocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune disease
25. The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/MP- lpr/lpr mice
26. Prolactin and interleukin-6 in neuropsychiatric lupus erythematosus
27. Cerebrospinal fluid immunoglobulins and neuronal antibodies in neuropsychiatric systemic lupus erythematosus and related conditions
28. Clinical neurology and brain histopathology in NZB/NZW F1 lupus mice
29. Evaluation of cerebrospinal anticardiolipin antibodies in lupus patients with neuropsychiatric manifestations
30. Disturbed immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in murine lupus
31. Cytokine gene expression in the MRL/lpr model of lupus nephritis
32. Astrocytes regulate the developmental appearance of GABAergic and glutamatergic postsynaptic currents in cultured embryonic rat spinal neurons
33. - channels with differential sensitivity to zolpidem in embryonic rat hippocampal cells
34. Anticardiolipin antibodies in serum and cerebrospinal fluid from patients with systemic lupus erythematosus
35. TNF-alpha and IL-1 sequentially induce endothelial ICAM-1 and VCAM-1 expression in MRL/lpr lupus-prone mice
36. Inflammatory events at the blood brain barrier: Regulation of adhesion molecules, cytokines, and chemokines by reactive nitrogen and oxygen species
37. Evidence for intrathecal synthesis of autoantibodies in systemic lupus erythematosus with neurological involvement
38. Attenuation of sucrose consumption in mice by chronic mild stress and its restoration by imipramine
39. Differential effects of CD4(+) T cell depletion on inflammatory central nervous system disease, arthritis and sialadenitis in MRL/lpr mice
40. Effect of late modulation of nitric oxide production on murine lupus
41. Elevated production of interleukin 6 by hepatic MNC correlates with ICAM-1 expression on the hepatic sinusoidal endothelial cells in autoimmune MRL/lpr mice
42. Binding sites for immune components in human choroid plexus
43. Psychiatric aspects of systemic lupus erythematosus
44. Animal model of depression
45. Depression: A new animal model sensitive to antidepressant treatments
46. Involvement of cytokines in acute neurodegeneration in the CNS
47. Cerebrospinal fluid: Blood-brain barrier, brain edema, and hydrocephalus
48. Brain-reactive antibodies and behavior of autoimmune MRL-lpr mice
49. Blunted sensitivity to sucrose in autoimmune MRL-lpr mice: A curve-shift study
50. Reduced corticotropin-releasing factor and enhanced vasopressin gene expression in brains of mice with autoimmunity-induced behavioral dysfunction
51. A behavioral profile of autoimmune lupus-prone MRL mice
52. Disturbed emotionality in autoimmune MRL-lpr mice
53. Increased TUNEL-staining in brains of autoimmune Fas-deficient mice
54. Progressive atrophy of pyramidal neuron dendrites in autoimmune MRL-lpr mice
55. Behaviour and immune status of MRL mice in the postweaning period
56. Neurobehavioral alteration in autoimmune mice
57. Altered neurotransmission in brains from autoimmune mice: Pharmacological and neurochemical evidence
58. Glucocorticoid toxicity in the hippocampus: In vitro demonstration
59. Magnetic resonance spectroscopy and positron emission tomography scanning in neuropsychiatric systemic lupus erythematosus
60. Behaviour of MRL mice: An animal model of disturbed behaviour in systemic autoimmune disease
61. Murine models of lupus
62. Animal behavioural studies in the evaluation of antidepressant drugs
63. Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement
64. Psychiatric symptoms before systemic lupus erythematosus is diagnosed
65. Inflammatory central nervous system disease in lupus-prone MRL/lpr mice: Comparative histologic and immunohistochemical findings
66. Evaluation of memory, learning ability, and clinical neurologic function in pathogen-free mice with systemic lupus erythematosus
67. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease - Increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered N-G-monomethyl-L-arginine
68. CD4 effector cells in autoimmune diseases of the central nervous system
69. Psychiatric symptoms in systemic lupus erythematosus - An update
70. Cognitive and emotional disturbances in systemic lupus erythematosus
71. Roles of CNS macrophages in neurodegeneration
72. Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons
73. The study of anticardiolipin antibodies and interleukin-6 in cerebrospinal fluid and blood of Chinese patients with systemic lupus erythematosus and central nervous system involvement
74. Increase in ICAM-1 and VCAM-1 expression in the brain of autoimmune mice